Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Jul 14, 2013; 19(26): 4155-4165
Published online Jul 14, 2013. doi: 10.3748/wjg.v19.i26.4155
Published online Jul 14, 2013. doi: 10.3748/wjg.v19.i26.4155
Figure 4 Effect of RNA interference-mediated inhibition of CDX2 mRNA and protein expression and downregulation of CDX2 on apoptosis in vivo.
A: mRNA expression level of CDX2 was determined by semiquantitative reverse-transcriptase polymerase chain reaction; B: Protein expression level of CDX2 was determined by western blotting; C: Tumor cell apoptosis was assessed by HE staining and TUNEL assay. CDX2 siRNA induced more apoptosis of tumor cells (× 400); D: Relative tumor volume (RTV) of nude mice in each group is presented. Each time point represents the mean RTV for each group. RTV in the SGC7901/DDP + small interfering RNA (siRNA)-CDX2 group was smaller than that in control animals. aP < 0.05 for SGC7901/DDP + siRNA-CDX2 cells vs SGC7901/DDP + siRNA-NC cells and SGC7901/DDP cells. Lane 1: SGC7901/DDP + siRNA-CDX2 cells; Lane 2: SGC7901/DDP + siRNA-NC cells; Lane 3: SGC7901/DDP cells. GAPDH: Glyceraldehyde 3-phosphate dehydrogenase.
- Citation: Yan LH, Wang XT, Yang J, Lian C, Kong FB, Wei WY, Luo W, Xiao Q, Xie YB. Reversal of multidrug resistance in gastric cancer cells by CDX2 downregulation. World J Gastroenterol 2013; 19(26): 4155-4165
- URL: https://www.wjgnet.com/1007-9327/full/v19/i26/4155.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i26.4155